The Modulation of PCSK9 and LDLR by Supercritical CO2 Extracts of Mentha longifolia and Isolated Piperitone Oxide, an In Vitro Study
Open Access
- 25 June 2021
- Vol. 26 (13), 3886
- https://doi.org/10.3390/molecules26133886
Abstract
In the present study the ability of supercritical carbon dioxide (SCO2) extracts of M. longifolia L. leaves to modulate low-density lipoprotein receptor (LDLR) and proprotein convertase subtilisin/kexin type 9 (PCSK9) expression was evaluated in cultured human hepatoma cell lines Huh7 and HepG2. Two SCO2 extracts, one oil (ML-SCO2) and a semisolid (MW-SCO2), were subjected to detailed chemical characterization by mono- and bidimensional nuclear magnetic resonance (1D, 2D-NMR), gas chromatography coupled with mass spectrometry (GC-MS) and liquid chromatography coupled with mass spectrometry (LC-MS). Chemical analysis revealed significant amounts of fatty acids, phytosterols and terpenoids. ML-SCO2 was able to induce LDLR expression at a dose of 60 µg/mL in HuH7 and HepG2 cell lines. Furthermore, ML-SCO2 reduced PCSK9 secretion in a concentration-dependent manner in both cell lines. Piperitone oxide, the most abundant compound of the volatile constituent of ML-SCO2 (27% w/w), was isolated and tested for the same targets, showing a very effective reduction of PCSK9 expression. The overall results revealed the opportunity to obtain a new nutraceutical ingredient with a high amount of phytosterols and terpenoids using the SCO2 extraction of M. longifolia L., a very well-known botanical species used as food. Furthermore, for the first time we report the high activity of piperitone oxide in the reduction of PCSK9 expression.This publication has 27 references indexed in Scilit:
- Biocidal Compounds from Mentha sp. Essential Oils and Their Structure–Activity RelationshipsChemistry & Biodiversity, 2017
- Nutraceuticals, A New Challenge for Medicinal ChemistryCurrent Medicinal Chemistry, 2016
- Liver fat accumulation is associated with circulating PCSK9Annals of Medicine, 2016
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemiaEndocrine, 2016
- Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical PracticeHigh Blood Pressure & Cardiovascular Prevention, 2015
- Inhibition of PCSK9 Transcription by Berberine Involves Down-regulation of Hepatic HNF1α Protein Expression through the Ubiquitin-Proteasome Degradation PathwayJournal of Biological Chemistry, 2015
- Supercritical Fluid Extraction of Plant Flavors and FragrancesMolecules, 2013
- Nutraceuticals: Facts and fictionPhytochemistry, 2007
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: Effects of apolipoprotein E deficiency and probucol or phytosterol treatmentMetabolism, 2001